The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Amgen; Eisai; Pfizer; Shire
Effect of pegfilgrastim on-body injector (OBI) on cancer care: A real-world health system and interrupted time series analysis.
 
Junji Lin
No Relationships to Disclose
 
Aylin Yucel
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Mark S. Walker
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Celgene (Inst); Eisai (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst)
 
Nancy Perrin
No Relationships to Disclose
 
Charles Bowers
Employment - Amgen; Amgen (I)
Stock and Other Ownership Interests - Amgen (I)
 
Maxine D. Fisher
Research Funding - AstraZeneca; Eisai; Genentech; Novartis; Pfizer
 
Mark Bensink
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Lee Steven Schwartzberg
Honoraria - Amgen; NanoString Technologies; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Genomic Health; Helsinn Therapeutics; Pfizer; Spectrum Pharmaceuticals; Tesaro